Applied Evidence

Diabetes and alcohol use: Detecting at-risk drinking

Author and Disclosure Information

Asking a simple question helps uncover at-risk drinking in patients with diabetes, and brief office interventions have proven effective in modifying behavior.


 

References

PRACTICE RECOMMENDATIONS

Ask a question such as “How many drinks containing alcohol did you have on a typical day when you were drinking in the last year?” to ascertain a patient’s quantity of alcohol use. A

Apply elements of the FRAMES approach to help patients curtail at-risk drinking—eg, use elevated HbA1c levels as evidence of a need to change behavior. A

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series

There are enough challenges in controlling diabetes mellitus without the hindrance of undetected problematic alcohol use. The good news is that asking a single nonthreatening question can help you detect at-risk drinking—defined by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as 5 or more drinks on one occasion or more than 14 drinks per week for men; and 4 or more drinks on one occasion or more than 7 drinks per week for women.1,2 And, for patients who may be compromising their diabetes care and overall health through problem drinking, brief intervention techniques used in the office can enable them to reduce alcohol consumption significantly.

When alcohol becomes a problem in diabetes care

Several studies have explored the long-term benefits of moderate alcohol use on glycemic control—with mixed results. A 2007 study found that diabetes patients who drink 1 glass of wine per day exhibited a lower fasting glucose level than abstainers after 3 months.3 There was no difference, however, on postprandial glucose levels. A 2008 study found that individuals who drank one to 2 glasses of wine per day for a month had lower fasting serum insulin levels relative to when they have abstained for a month,4 although levels of fasting plasma cholesterol, HDL cholesterol, glucose, and hemoglobin A1c (HbA1c) remained unchanged relative to periods of abstinence.4

Furthermore, rates of coronary heart disease and CHD mortality in a meta-analysis were significantly lower in 3 categories of alcohol consumption (<6 g/d, 6 to <18 g/d, and ≥18 g/d) compared with abstinence.5 Nondrinkers also had a greater risk of total mortality compared with the lightest drinking group. Notably, however, the lower limit of the highest drinking category was only 1.5 drinks per day.

How big is the problem? In a study of insulin-treated patients seen for severe hypoglycemia, 17% had been drinking before the episode.6 In a primary care sample, 28% of randomly selected patients with type 2 diabetes met Diagnostic and Statistical Manual of Mental Disorders-IV criteria for a lifetime incidence of alcohol abuse and 13% met either current or lifetime criteria for alcohol dependence.7 Another study of primary care patients with diabetes8 found that 13.4% met NIAAA criteria for at-risk drinking; 11.1% of these at-risk drinkers met criteria for current alcohol dependence. (According to the NIAAA, the rate of at-risk/heavy drinking among US adults is 30%, and about one in 4 heavy drinkers meets the criteria for alcohol abuse or dependence.1)

Detrimental effects with immoderate drinking. Individuals who engage in at-risk drinking, as defined by the NIAAA, are at increased risk for alcohol dependence9 and associated complications such as diabetic neuropathy and retinopathy,10 atherosclerosis,11 and total and CHD mortality.3,12 Heavy drinking also interferes with neuroendocrine, gastrointestinal, and sexual function,13 and its interaction with diabetes increases the risk for hepatocellular carcinoma after controlling for hepatitis B and C serology.14

Interference with diabetes control. Research examining the short-term effect of alcohol use has produced contradictory results, partly due to differences among studies, such as whether alcohol is administered with a meal and whether a fasting glucose level is measured.15 However, alcohol affects glycemic control and, when used excessively, can impair glucose production.16,17 Alcohol may induce hypoglycemia,10,18 and even small amounts may jeopardize diabetes control.13 In a study of patients with insulin-treated diabetes, alcohol use in the presence of mild hypoglycemia increased diastolic blood pressure or exacerbated hypoglycemia-related cognitive deficits.19 Another concern—in both the short and long term—is that alcohol interacts negatively with certain diabetes medications. It is more likely to induce hypoglycemia in the presence of sulfonylurea medications.10 Chlorpropamide decreases the rate of ethanol elimination from the blood.20 And, in those taking metformin, excessive alcohol use elevates risk for lactic acidosis. 21

Diminished self-care. Alcohol use can interfere with self-care,22,23 which is a crucial component of diabetes treatment.24 It may lead to reduced eating16 or to decreased willingness to adhere to prescribed dietary regimens.13 It also impairs other self-care behaviors13,15,25 such as self-monitoring blood glucose and showing up for medical appointments.26 In a large, diverse sample of patients with diabetes,24 heavy drinkers had the highest rates of morbidity. Importantly, alcohol and diabetes self-care behavior were significantly negatively associated. Studies of ethnic minority samples have yielded comparable results.27

Pages

Recommended Reading

Diabetes Impairs Patients' Ability to Exercise
Type 2 Diabetes ICYMI
Current Guidelines Provide More Realistic Exercise Goals
Type 2 Diabetes ICYMI
Traditional or centralized models of diabetes care: The multidisciplinary diabetes team approach
Type 2 Diabetes ICYMI
Traditional or centralized models of diabetes care: The multidisciplinary diabetes team approach
Type 2 Diabetes ICYMI
Nontraditional or noncentralized models of diabetes care: Medication therapy management services
Type 2 Diabetes ICYMI
Nontraditional or noncentralized models of diabetes care: Medication therapy management services
Type 2 Diabetes ICYMI
Bromocriptine: Its place in type 2 diabetes Tx
Type 2 Diabetes ICYMI
Clinical Pharmacy Specialists Help Achieve an LDL-Cholesterol Performance Goal in Veterans With Diabetes
Type 2 Diabetes ICYMI
Insulin Pump Therapy for the Patient With Diabetes
Type 2 Diabetes ICYMI
The bittersweet of steroid therapy
Type 2 Diabetes ICYMI